Vitamin D, in addition to its classical functions in bone homeostasis, has a modulatory and regulatory role in multiple processes, including host defense, inflammation, immunity, and epithelial For our review we have taken into consideration the recently published reviews (systematic or not) on the topic.
Summary
Vitamin D, in addition to its classical functions in bone homeostasis, has a modulatory and regulatory role in multiple processes, including host defense, inflammation, immunity, and epithelial In an era of debate on the rational use of expensive medicines, particularly in countries with limited resources, the use of vitamin D as a strategy to reduce the frequency and severity of respiratory infections needs to be seriously considered. However, the current evidence of efficacy of vitamin D in preventing viral respiratory infections is inconsistent. There is a lack of prospective cohort studies with detailed vitamin D and immune profiling of the patients studied.
In this review we attempt to unveil the pathogenic mechanisms underlying vitamin D treatment during respiratory viral infections, as introduced by several in vitro and in vivo/ex vivo models that have been published so far. More importantly, in the second part of the review, we focus on translating these findings into a clinical perspective and, through reviewing currently published randomized clinical trials and cohort studies, we aim to conclude whether vitamin D supplementation has been identified as a promising adjuvant during common cold episodes or exacerbations of asthma or whether current and future vitamin D trials are a waste of funding, as recently highlighted in BMJ. 1, 2 For our review we have taken into consideration the recently published reviews (systematic or not) on the topic. [3] [4] [5] Our review aims † These authors contributed equally to this paper. responses. 33 Although defensin was induced by rhinovirus in primary epithelial cells, defensin showed no direct antiviral activity towards rhinovirus. 36 However, defensin inhibited RSV by destabilizing the viral envelope and consequently inhibiting cellular entry. and have poor control of the disease. 69 In a recent study in the United
States, the group of older adults with asthma who presented with vitamin D deficiency had an increased number of hospitalizations and increased morbidity. 70 However, old people also probably spent less time outside and consequently were less exposed to UV-B radiation. In addition, intermittent high-dose vitamin D supplementation seems not to work as well as daily supplementation. [82] [83] [84] [85] Bergman reported in a systematic review and a meta-analysis of published randomized controlled trials that vitamin D has a protective effect against RTIs; specifically, when using daily doses instead of intermittent large bolus doses at long intervals (1-3 mo) of vitamin D, a significantly better therapeutic effect is achieved. 82, 86 When bolus vitamin D 3 (250 000 IU) was given once in November to young healthy adults, there was a robust increase in plasma 25(OH)D after 5 days, but after 90 days this effect was lost. 87 Intermittent dosing with vitamin D seems also to be less effective in reducing the incidence of exacerbations of asthma despite its favorable role in preventing bone fractures.
| SUMMARY
However, an intermittent dosing scheme might improve adherence and could be directly observed.
The appropriate form of vitamin D supplementation might vary between the different respiratory conditions, and indeed between supplementation for respiratory and bone disease and an evidencebased consensus on both the dose and the frequency needs to be reached.
| VITAMIN D SUPPLEMENTATION IN PREVENTING ARIs IN HEALTHY PEOPLE
The results from clinical trials of vitamin D supplementation in preventing and/or treating common colds in healthy subjects are inconsistent (Table 1) In a double-blind, placebo-controlled trial conducted in India, 230
mother-newborn pairs were randomized to receive, monthly for 
